在某些博主的宣传之下，红霉素软膏被当作"万能药"，用于蚊虫叮咬、湿疹、痘痘、脚气、日常护肤等，甚至还有不少人拿来涂宝宝的"红屁屁"（尿布 疹）。这个"万能药"究竟该怎么用？↓↓↓ 1 红霉素软膏常见的滥用场景 ■ 宝宝的"红屁屁"（尿布疹） "红屁屁"是尿布皮炎的俗称，也被称为尿布疹。这是一种常见的婴儿皮肤病，主要表现为尿布覆盖区域的皮肤发红、炎症，可能伴有皮疹、糜烂或脱皮。 绝大部分情况不建议单用红霉素软膏治疗"红屁屁"。 红霉素软膏被广泛应用于各种病症和场景，几乎是家家必备的常用药膏。但实际上，这些场景大多是滥用。 对于尿布疹的治疗，最核心的元素就是保湿、减少刺激及抗炎。要点如下： 具体的措施是更换尿布，用湿巾/湿毛巾轻柔擦拭干净皮肤，并及时补涂保湿乳；另外可根据炎症的严重程度选择氧化锌软膏、地奈德乳膏等对症外用 药。 此外，"红屁屁"有一定概率出现继发的细菌、真菌感染，如果出现继发感染，需要抗感染治疗。 注意皮肤炎症≠感染，抗感染治疗≠抗炎治疗。 蚊虫叮咬可以理解为虫咬引起的过敏反应。如出现严重的蚊虫叮咬，医生会让患者口服抗过敏药，也可能根据情况涂抹外用糖皮质激素软膏抗炎、促皮疹 消退止痒，大部分叮咬即 ...

Core Insights - The pharmaceutical industry is witnessing significant strategic collaborations, with companies like Kangzheng Pharmaceutical partnering with global giants like Novartis to enhance their market presence in specialized fields such as ophthalmology and dermatology [1] Group 1: Kangzheng Pharmaceutical's Strategic Moves - Kangzheng Pharmaceutical has signed a distribution agreement with Novartis, gaining exclusive rights for two ophthalmic drugs in mainland China, indicating a strong commitment to the ophthalmology sector [1] - The company is also focusing on its dermatology segment through the spin-off of its skin health business, Dermy Pharmaceuticals, which has submitted a listing application to the Hong Kong Stock Exchange [1] Group 2: Market Potential in Dermatology - The white spot disease (vitiligo) market is highlighted as a significant opportunity, with the treatment market projected to grow from 2.8 billion RMB in 2024 to approximately 21.9 billion RMB by 2035, reflecting a compound annual growth rate (CAGR) of 20.7% [2] - Dermy Pharmaceuticals is advancing its lead product, Ruxolitinib cream, which is the first and only FDA and EMA-approved topical JAK inhibitor for vitiligo, currently in the new drug application approval stage in China [3] Group 3: Other Dermatological Conditions - Psoriasis, affecting around 7.2 million patients in China, is seeing a shift towards biologics and small molecule drugs as preferred treatment options, with Dermy Pharmaceuticals' Tildrakizumab injection positioned as a second approved IL-23 monoclonal antibody in the market [4] - Atopic dermatitis, impacting over 54 million people in China, is expected to see its treatment market grow from 12.1 billion RMB in 2024 to 39.4 billion RMB by 2035, with Dermy Pharmaceuticals pursuing multiple pipeline strategies to address this demand [6][7] Group 4: Acne Treatment Innovations - Acne is a prevalent skin issue, with a reported prevalence of 8.1% in the Chinese population, leading to a growing market for effective skincare solutions [8] - Dermy Pharmaceuticals is leveraging its brand advantage with the launch of the Xiliao Duo series, targeting acne treatment and prevention, while also offering soothing products for atopic dermatitis and sensitive skin [8]

Core Viewpoint - Erythromycin ointment is widely used for various conditions, but its application is often inappropriate and constitutes misuse [1][3]. Misuse Scenarios - Erythromycin ointment is promoted as a "universal medicine" for conditions such as insect bites, eczema, acne, athlete's foot, and even for treating diaper rash in infants [3]. - For diaper rash, the primary treatment should focus on moisturizing, reducing irritation, and anti-inflammatory measures rather than solely relying on erythromycin ointment [4]. Treatment Recommendations - Effective treatment for diaper rash includes applying moisturizing creams, minimizing diaper wear time, and using appropriate topical medications based on the severity of inflammation [4]. - In cases of insect bites, while erythromycin ointment can reduce the risk of infection, it does not relieve itching or inflammation [5][6]. - Erythromycin ointment is not effective for eczema, where the treatment should focus on moisturizing and anti-inflammatory agents [7]. - For acne, erythromycin ointment is insufficient as acne treatment requires a multifaceted approach [8]. - Athlete's foot, a fungal infection, necessitates antifungal treatment, which erythromycin does not provide [9]. Appropriate Use Cases - The suitable application of erythromycin ointment is primarily for treating minor burns and wounds where there is a risk of infection [10][11]. - It can be used for minor abrasions and superficial burns after proper cleaning and disinfection, but should not be used continuously for more than one week [12].